Zu-Chian Chiang | Biotechnology | Best Researcher Award

Dr. Zu-Chian Chiang | Biotechnology | Best Researcher Award

Zu-Chian Chiang at Fujian Normal University, China.

Dr. Zu-Chian Chiang is a materials scientist and biomedical researcher specializing in antibody–drug conjugates (ADCs), aptamer-based therapeutics, and functional biomaterials for cancer therapy and regenerative medicine. With a strong foundation in chemical engineering and molecular design, his research spans across Taiwan and China, advancing innovative strategies in translational medicine.

Publication Profile

Scopus

Educational Details

  • Ph.D. in Materials and Chemical Engineering
    National United University, Taiwan | Sept 2008 – Jul 2014

    • Advisor: Prof. An-Chong Chao

    • Co-Advisor: Dr. Guo-Chung Dong, NHRI

  • M.S. in Chemistry
    Tunghai University, Taiwan | Sept 2005 – Aug 2007

    • Advisor: Prof. Feng-Di Lung

Professional Experience

Dr. Chiang has extensive postdoctoral research experience in interdisciplinary biomedical research.

  • Postdoctoral Fellow
    Fujian Normal University, Biomedical Research Center of Southern China (2019–Present)
    Focus: Development of ADCs and aptamers in cancer therapy under Prof. Qi Chen.

  • Postdoctoral Fellow
    Academia Sinica, Institute of Biological Chemistry (2016–2019)
    Participated in the Taiwan Protein Project (TPP) and the TSPA platform, supervised by Academician Hui-Kung Wang.

  • Postdoctoral Fellow
    Clinical Trial Center, National Taiwan University Hospital (2015–2016)
    Selected for the 3rd Biotech Elite Training Reserve Program (MOST). Mentored by Dr. Chih-Hao Chang.

Teaching Experience

  • Served as a Teaching Assistant (2005–2013) in a wide range of chemistry and chemical engineering subjects including Organic Chemistry, Physical Chemistry, Thermodynamics, and Instrumental Analysis at both Tunghai University and National United University.

Research Interest

  • Design and synthesis of functional peptides for cancer therapy and bone tissue regeneration

  • Development of biomicro- and macromolecular composites for regenerative medicine

  • Engineering antibody–drug conjugates (ADCs) for targeted cancer treatment

  • Construction of aptamers as molecular blockers, agonists, or antagonists in oncology applications

Author Metrics

  • Total Publications: 7 peer-reviewed journal articles

  • Total Citations: 93 (as of latest data)

  • h-index: 5

  • Research Interest Score: 49.5 (ResearchGate metric)

Top Noted Publication

Development of Novel CD47-Specific ADCs Possessing High Potency Against Non-Small Cell Lung Cancer in vitro and in vivo

Authors:
Z.C. Chiang (Zu-Chian Chiang), S. Fang (Shubin Fang), Y. Shen (Yangkun Shen), D. Cui, H. Weng, D. Wang, Y. Zhao, J. Lin (Jizhen Lin), Q. Chen (Qi Chen)

Journal:
Frontiers in Oncology
Year: 2022
Volume: 12
Article ID: 857927
DOI: 10.3389/fonc.2022.857927
Access: Article • Open Access
Article Type: Original Research

Author Roles:

  • First Author: Zu-Chian Chiang

  • Co-first Author: Shubin Fang (#)

  • Corresponding Authors: Jizhen Lin*, Qi Chen*

Summary:
This study presents the design and evaluation of novel CD47-targeting antibody–drug conjugates (ADCs) with high antitumor efficacy against non-small cell lung cancer (NSCLC), demonstrating promising therapeutic potential both in vitro and in vivo.

Conclusion

Dr. Zu-Chian Chiang is an emerging talent in the biotechnology research community, with a clear trajectory toward impactful innovation in cancer therapy and regenerative medicine. His demonstrated strengths in antibody–drug conjugates, biomaterials design, and molecular therapeutics showcase both technical expertise and translational vision.

 

Mozhgan Abasi | Biotechnology | Best Researcher Award

Assist. Prof. Dr. Mozhgan Abasi | Biotechnology | Best Researcher Award

Mozhgan Abasi at Mazandaran University of Medical Sciences, Iran.

Assist. Prof. Dr. Mozhgan Abasi is a Medical Biotechnology researcher with expertise in stem cell therapy, tissue engineering, genetic engineering, and bioinformatics. She earned her Ph.D. in Medical Biotechnology from Tabriz University of Medical Sciences, Iran, where she focused on lentiviral vector-mediated gene expression in apoptosis pathways. With a strong background in molecular and cellular biology, she has conducted extensive research in induced pluripotent stem cells (iPSCs), cancer stem cells, and non-coding RNA. Dr. Abasi is a member of multiple scientific societies, including the Iran Biotechnology Society and the iPS Biotechnology Team. Her work integrates molecular techniques, bioinformatics, and microbiological approaches to advance regenerative medicine and genetic research.

Publication Profile

Scopus

Orcid

Google Scholar

Educational Details

  • Ph.D. in Medical Biotechnology (2011-2017) – Tabriz University of Medical Sciences, Tabriz, Iran
    Thesis: Study on the effect of lentiviral vector-mediated 7SK snRNA overexpression on mRNA levels of apoptosis-related markers BCL2 and BAX in HEK293T cells.
  • M.Sc. in Molecular and Cellular Biology (2009-2011) – National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
    Thesis: The study of dopaminergic differentiation of Nurr1 and GPX1 co-expressing ES cells induced by BBA.
  • B.Sc. in Biotechnology (2004-2008) – Department of Biology, Faculty of Science, Al Zahra University, Tehran, Iran.

Professional Experience

Dr. Mozhgan Abasi is an Assistant Professor specializing in Medical Biotechnology. She has extensive expertise in stem cell research, genetic engineering, bioinformatics, and cancer biology. Her research focuses on iPS (induced pluripotent stem) cell generation, stem cell differentiation, tissue engineering, and nanoporous biomaterials. With a strong foundation in molecular and cellular biology, she has contributed significantly to understanding stem cell therapy and regenerative medicine.

Dr. Abasi has been an active member of multiple professional societies, including the Iran Bioinformatics Society (IBS), Iran Genetic Society (IGS), Iran Biotechnology Society, and the iPS Biotechnology Team (IBT). She has extensive experience in molecular techniques such as gene expression analysis, cloning, viral and non-viral gene transfer, and protein analysis methods like Western blotting and immunocytochemistry. Additionally, she is proficient in a range of bioinformatics tools used for primer design, shRNA analysis, gene expression studies, and molecular dynamics simulations.

Research Interest

  • Stem Cell Therapy
  • Tissue Engineering
  • Induced Pluripotent Stem Cells (iPSCs)
  • Cancer Stem Cells
  • Immune System Research
  • Microarray Analysis
  • Nanoporous Biomaterials
  • Bioinformatics & Non-Coding RNA
  • Genetic Engineering

Author Metrics

  • Total Citations: 1,821+

  • h-index: 17

  • i10-index: 6+

Top Noted Publication

  • Carbon nanotubes: properties, synthesis, purification, and medical applications

    • Citations: 1,462

    • Journal: Nanoscale Research Letters

    • Year: 2014

  • The effect of topography on differentiation fates of matrigel-coated mouse embryonic stem cells cultured on PLGA nanofibrous scaffolds

    • Citations: 101

    • Journal: Tissue Engineering Part A

    • Year: 2012

  • Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer

    • Citations: 94

    • Journal: Journal of Microencapsulation

    • Year: 2014

  • Recent advances on nanomaterials-based fluorimetric approaches for microRNAs detection

    • Citations: 91

    • Journal: Materials Science and Engineering: C

    • Year: 2019

  • Anti-tumoral properties of Punica granatum (Pomegranate) peel extract on different human cancer cells

    • Citations: 73

    • Journal: Asian Pacific Journal of Cancer Prevention

    • Year: 2015

  • Anti-proliferative properties of Cornus mass fruit in different human cancer cells

    • Citations: Over 50

    • Journal: Asian Pacific Journal of Cancer Prevention

    • Year: Not specified

Conclusion

Assist. Prof. Dr. Mozhgan Abasi is an exceptional researcher with significant contributions to biotechnology, genetic engineering, and regenerative medicine. Her high citation impact, strong expertise in molecular biology, and interdisciplinary research focus make her a strong contender for the Best Researcher Award.

While her achievements are commendable, further expanding international collaborations, increasing high-impact publications, and securing major research grants would solidify her position as a leading global researcher. Overall, Dr. Abasi is highly deserving of recognition for her contributions to the scientific community and biotechnology advancements.